سعر كلافوران 500 مجم فيال 2026

Claforan 500mg i.m/i.v.vial: Cefotaxime (Sanofi).

• Treatment of serious infections due to susceptible bacteria (lower respiratory, GU, gynecologic, skin/skin structure, intra-abdominal, bone/joint, CNS including meningitis, bacteremia/septicemia) as labeled for cefotaxime injection (US CLAFORAN SPL opened).Population: See labelDailyMed (U.S. National Library of Medicine)

• Most common: local injection-site reactions; hypersensitivity (rash, pruritus, fever, eosinophilia); GI (colitis, diarrhea, nausea, vomiting). Less common hematologic and hepatic enzyme elevations.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Contraindicated in patients with known hypersensitivity to cefotaxime sodium or the cephalosporin group of antibiotics.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Cross-sensitivity with penicillins possible; serious hypersensitivity may require epinephrine. Rapid central-line bolus (<60 s) associated with life-threatening arrhythmia — administer as labeled. CDAD reported with nearly all antibacterials including CLAFORAN.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• AminoglycosidesPossible additive nephrotoxicity; monitor renal function.DailyMed (U.S. National Library of Medicine)
• ProbenecidMay increase cephalosporin serum levels by reducing renal excretion.DailyMed (U.S. National Library of Medicine)

• Historical US Pregnancy Category B; animal studies without evidence of embryotoxicity/teratogenicity at studied doses; no adequate well-controlled studies in pregnant women — use only if clearly needed (US CLAFORAN label).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Cefotaxime: Bactericidal; inhibits bacterial cell-wall synthesis via penicillin-binding proteins; parenteral third-generation cephalosporin.